Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study

被引：0

作者：

Pishvaian, M. J. ^{[1
]}

Weiss, G. J. ^{[2
]}

Falchook, G. S. ^{[3
]}

Yee, N. ^{[4
]}

Gil-Martin, M. ^{[5
]}

Shahda, S. ^{[6
]}

Moreno, V. ^{[7
]}

Brana, I. ^{[8
]}

Crittenden, M. ^{[9
,10
]}

Formenti, S. ^{[11
]}

Al-Rajabi, R. ^{[12
]}

Papadopoulos, K. P. ^{[13
]}

Stankevich, E. ^{[14
]}

Feng, M. ^{[14
]}

Li, J. ^{[15
]}

Mathias, M. ^{[16
]}

Kroog, G. ^{[16
]}

Lowy, I. ^{[16
]}

Fury, M. G. ^{[16
]}

机构：

[1] Georgetown Univ, Med Ctr, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[2] Univ Arizona, Coll Med, Dept Internal Med, Phoenix, AZ USA

[3] HealthONE, Drug Dev, Sarah Cannon Res Inst, Denver, CO USA

[4] Penn State Canc Inst, Hematol Oncol, Hershey, PA USA

[5] Inst Catala Oncol, Lhospitalet De Llobregat, Spain

[6] Indiana Univ Sch Med, Indiana Univ Melvin Bren Simon Canc Ctr, Indianapolis, IN 46202 USA

[7] Hosp Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

[8] Vall DHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain

[9] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA

[10] Oregon Clin, Portland, OR USA

[11] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA

[12] Univ Kansas, Ctr Canc, Div Hematol Oncol, Dept Internal Med, Kansas City, KS USA

[13] START, Clin Res, San Antonio, TX USA

[14] Regeneron Pharmaceut Inc, Clin Sci, Basking Ridge, NJ USA

[15] Regeneron Pharmaceut Inc, Biostat & Data Management, Basking Ridge, NJ USA

[16] Regeneron Pharmaceut Inc, Clin Sci, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1151P

引用

页数：1